Tracing donor-MHC class II reactive B cells in mouse cardiac transplantation: delayed CTLA4-Ig treatment prevents memory alloreactive B-cell generation

J Yang, J Chen, JS Young, Q Wang, D Yin… - …, 2016 - journals.lww.com
J Yang, J Chen, JS Young, Q Wang, D Yin, R Sciammas, AS Chong
Transplantation, 2016journals.lww.com
Background The dual role of B cells as drivers and suppressors of the immune responses
have underscored the need to trace the fate of B cells recognizing donor major
histocompatibility complex class I and class II after allograft transplantation. Methods In this
study, we used donor class II tetramers to trace the fate of IE d–specific B cells after
immunization with BALB/c spleen cells or cardiac transplantation, in naive or sensitized
C57BL/6 recipients. We combined this approach with genetic lineage tracing of memory B …
Background
The dual role of B cells as drivers and suppressors of the immune responses have underscored the need to trace the fate of B cells recognizing donor major histocompatibility complex class I and class II after allograft transplantation.
Methods
In this study, we used donor class II tetramers to trace the fate of IE d–specific B cells after immunization with BALB/c spleen cells or cardiac transplantation, in naive or sensitized C57BL/6 recipients. We combined this approach with genetic lineage tracing of memory B cells in activation-induced cytidine deaminase regulated Cre transgenic mice crossed to the ROSA26-enhanced yellow fluorescent protein reporter mice to track endogenous IE d–specific memory B cell generation.
Results
Immunization with BALB/c splenocytes or heart transplantation induced an expansion and differentiation of IE d–specific B cells into germinal center B cells, whereas BALB/c heart transplantation into sensitized recipients induced the preferential differentiation into antibody-secreting cells. A 10.8-fold increase in the frequency of IE d-specific memory B cells was observed by day 42 postimmunization. Treatment with CTLA4-Ig starting on day 0 or day 7 postimmunization abrogated IE d–specific memory B cell generation and sensitized humoral responses, but not if treatment commenced on day 14.
Conclusions
The majority of donor-specific memory B cells are generated between days 7 and 14 postimmunization, thus revealing a flexible timeframe whereby delayed CTLA4-Ig administration can inhibit sensitization and the generation of memory graft-reactive B cells.
Lippincott Williams & Wilkins